which glp 1 agonists are approved for weight loss Indications GLP-1/GIP RA Summary Sheet and Beyond! List of approved and pending
Description
The main target of current PD treatment is the restoration of dopamine levels, as the deficiency of this neurotransmitter is the main cause of PD

These medications, originally developed to treat diabetes and support weight management, have been linked to severe gastrointestinal injuries, stomach paralysis, vision loss, and other serious health complications

29 GLP-1, an endocrine hormone, is secreted by enteroendocrine L-cells located in the distal jejunum, ileum, and colon in response to nutrient ingestion and neuroendocrine stimulation

The most pronounced improvements in BC were observed after 3 and 6 months of treatment, whereas after 12 months these beneficial effects tended to diminish
Baseline Demographics and Medication Profiles A total of 125 youth were included (median age 14.83 years), with 113 on metformin and 12 on GLP-1RA therapy

Type 1 diabetes Tresiba (or another basal insulin) is essential for type 1 diabetes management
